Critics Warn TrumpRx Will Further Enrich Big Pharma, Not Reduce Drug Prices
Trump’s son is on the board of a prescription drug platform that may benefit from the direct-to-patient medicine sales.
This post has been syndicated from Truthout, where it was published under this address.
Critics Warn TrumpRx Will Further Enrich Big Pharma, Not Reduce Drug Prices Read Post »